Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: A comparison to native L-cells

Journal of Molecular Endocrinology

Volumn 56, Issue 3, 2016, Pages 201-211

  Kuhre, Rune Ehrenreich ^a   Albrechtsen, Nicolai Jacob Wewer ^a   Deacon, Carolyn Fiona ^a   Balk Møller, Emilie ^a   Rehfeld, Jens Frederik ^b   Reimann, Frank ^c   Gribble, Fiona Mary ^c   Holst, Jens Juul ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

GLP 1 producing cell lines; L cells; Peptide production

Indexed keywords

FORSKOLIN; GLICENTIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; ISOBUTYLMETHYLXANTHINE; NEUROTENSIN; OXYNTOMODULIN; POTASSIUM CHLORIDE; PROGLUCAGON; PROPROTEIN CONVERTASE 1; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE; PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; GLUTAG CELL LINE; HORMONE DETERMINATION; HUMAN; HUMAN CELL; IMMUNOASSAY; L CELL LINE; MICROARRAY ANALYSIS; MOUSE; NCI H716 CELL LINE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STC 1 CELL LINE; ANIMAL; BIOSYNTHESIS; CHEMISTRY; METABOLISM; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; SECRETION (PROCESS);

ANIMALS; CELL LINE; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-SECRETING CELLS; INSULIN-SECRETING CELLS; MICE; PEPTIDE BIOSYNTHESIS; PEPTIDE FRAGMENTS; PROGLUCAGON;

EID: 84969142000     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-15-0293     Document Type: Article

References (57)

1. Adriaenssens A, Lam BY, Billing L, Skeffington K, Sewing S, Reimann F & Gribble F 2015 A transcriptome-led exploration of molecular mechanisms regulating somatostatin-producing D-Cells in the gastric epithelium. Endocrinology 156 3924-3936. (doi:10.1210/en.2015-1301)
2. Børglum Jensen T, Hilsted L & Rehfeld JF 1999 Library of sequencespecific radioimmunoassays for human chromogranin A. Clinical Chemistry 45 549-560.
3. Brand CL, Jorgensen PN, Knigge U, Warberg J, Svendsen I, Kristensen JS & Holst JJ 1995 Role of glucagon in maintenance of euglycemia in fed and fasted rats. American Journal of Physiology 269 E469-477.
4. Bruïne A, Dinjens WM, Pijls MJ, Linden EM, Rousch MM, Moerkerk P, Goeij APM & Bosnian F 1992 NCI-H716 cells as a model for endocrine differentiation in colorectal cancer. Virchows Archiv B 62 311-320.
5. Buhl T, Thim L, Kofod H, Orskov C, Harling H & Holst JJ 1988 Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine. Journal of Biological Chemistry 263 8621-8624.
6. Cao X, Flock G, Choi C, Irwin DM & Drucker DJ 2003 Aberrantregulation of human intestinal proglucagon gene expression in the NCI-H716 cell line. Endocrinology 144 2025-2033. (doi:10.1210/en.2002-0049)
7. Cheung AT, Dayanandan B, Lewis JT, Korbutt GS, Rajotte RV, Bryer-Ash M, Boylan MO, Wolfe MM & Kieffer TJ 2000 Glucosedependent insulin release from genetically engineered K cells. Science 290 1959-1962. (doi:10.1126/science.290.5498.1959)
8. Cordier-Bussat M, Bernard C, Haouche S, Roche C, Abello J, Chayvialle JA & Cuber JC 1997 Peptones stimulate cholecystokinin secretion and gene transcription in the intestinal cell line STC-1. Endocrinology 138 1137-1144.
9. Deacon CF, Nauck MA, Meier J, Hucking K & Holst JJ 2000 Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. Journal of Clinical Endocrinology and Metabolism 85 3575-3581. (doi:10.1210/jcem.85.10.6855)
10. Dirksen C, Jorgensen NB, Bojsen-Moller KN, Kielgast U, Jacobsen SH, Clausen TR, Worm D, Hartmann B, Rehfeld JF, Damgaard M, et al. 2013 Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. International Journal of Obesity 37 1452-1459. (doi:10.1038/ijo.2013.15)
11. Drucker DJ, Jin T, Asa SL, Young TA & Brubaker PL 1994 Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Molecular Endocrinology 8 1646-1655.
12. Egerod KL, Engelstoft MS, Grunddal KV, Nøhr MK, Secher A, Sakata I, Pedersen J, Windeløv JA, Füchtbauer E-M, Olsen J, et al. 2012 A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology 153 5782-5795. (doi:10.1210/en.2012-1595)
13. Eiki J, Saeki K, Nagano N, Iino T, Yonemoto M, Takayenoki-Iino Y, Ito S, Nishimura T, Sato Y, Bamba M, et al. 2009 A selective small molecule glucagon-like peptide-1 secretagogue acting via depolarizationcoupled Ca (2+) influx. Journal of Endocrinology 201 361-367. (doi:10.1677/JOE-08-0528)
14. Fahrenkrug J & Schaffalitzky de Muckadell OV 1977 Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. Journal of Laboratory and Clinical Medicine 89 1379-1388.
15. Geraedts MC, Troost FJ & Saris WH 2009 Peptide-YY is released by the intestinal cell line STC-1. Journal of Food Science 74 H79-82. (doi:10.1111/j.1750-3841.2009.01074.x)
16. Grant SGN, Seidman I, Hanahan D & Bautch VL 1991 Early invasiveness characterizes metastatic carcinoid tumors in transgenic mice. Cancer Research 51 4917-4923.
17. Habib AM, Richards P, Cairns LS, Rogers GJ, Bannon CAM, Parker HE, Morley TCE, Yeo GSH, Reimann F & Gribble FM 2012 Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 153 3054-3065. (doi:10.1210/en.2011-2170)
18. Hand KV, Bruen CM, O’Halloran F, Giblin L & Green BD 2010 Acute and chronic effects of dietary fatty acids on cholecystokinin expression, storage and secretion in enteroendocrine STC-1 cells. Molecular Nutrition & Food Research 54 (Supplement 1) S93-S103. (doi:10.1002/mnfr.200900343)
19. Hand KV, Bruen CM, O’Halloran F, Panwar H, Calderwood D, Giblin L & Green BD 2013 Examining acute and chronic effects of short- andlong-chain fatty acids on peptide YY (PYY) gene expression, cellularstorage and secretion in STC-1 cells. European Journal of Nutrition 52 1303-1313. (doi:10.1007/s00394-012-0439-9)
20. Hartmann B, Johnsen AH, Orskov C, Adelhorst K, Thim L & Holst JJ 2000 Structure, measurement, and secretion of human glucagon-like peptide-2. Peptides 21 73-80. (doi:10.1016/S0196-9781(99)00176-X)
21. Holst JJ 1983 Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours. Diabetologia 24 359-365.
22. Holst JJ 2007 The physiology of glucagon-like peptide 1. Physiological Reviews 87 1409-1439. (doi:10.1152/physrev.00034.2006)
23. Holst JJ 2010 Glucagon and glucagon-like peptides 1 and 2. Results and Problems in Cell Differentiation 50 121-135.
24. Holst JJ & Bersani M 1991 Assays for peptide products of somatostatin gene expression. Metods Neurosciences 5 3-22.
25. Holst JJ, Bersani M, Johnsen AH, Kofod H, Hartmann B & Orskov C 1994 Proglucagon processing in porcine and human pancreas. Journal of Biological Chemistry 269 18827-18833.
26. Katsuma S, Hirasawa A & Tsujimoto G 2005 Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochemical and Biophysical Research Communications 329 386-390. (doi:10.1016/j.bbrc.2005.01.139)
27. Kieffer TJ, Huang Z, McIntosh CH, Buchan AM, Brown JC & Pederson RA 1995 Gastric inhibitory polypeptide release from a tumor-derived cell line. American Journal of Physiology 269 E316-322.
28. Krarup T & Holst JJ 1984 The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera. Regulatory Peptides 9 35-46.
29. Kuhre RE, Albrechtsen NW, Windeløv JA, Svendsen B, Hartmann B & Holst JJ 2014a GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell lines. Peptides 55 6. (doi:10.1016/j.peptides.2014.01.020)
30. Kuhre RE, Gribble FM, Hartmann B, Reimann F, A. WJ, Rehfeld JF & Holst JJ 2014b Fructose stimulates GLP-1 but not GIP secretion in mice, rats and humans. American Journal of Physiology: Gastrointestinal and Liver Physiology 306 G622-G630. (doi:10.1152/ajpgi.00372.2013)
31. Kuhre RE, Bechmann LE, Wewer Albrechtsen NJ, Hartmann B & Holst JJ 2015 Glucose stimulates neurotensin secretion from the rat small intestine by mechanisms involving SGLT1 and GLUT2 leading to cell depolarization and calcium influx. American Journal of Physiology. Endocrinology and Metabolism 308 E1123-E1130. (doi:10.1152/ajpendo.00012.2015)
32. Lee YC, Asa SL & Drucker DJ 1992 Glucagon gene 5’-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice. Journal of Biological Chemistry 267 10705-10708.
33. Margolskee R, Dyer J, Kokrashvili Z, Salmon K, Ilegems E, Daly K, Maillet E, Ninomiya Y, Mosinger B & Shirazi-Beechey S 2007 T1R3 and gustducin in gut sense sugars to regulate expression of Na+- glucose cotransporter 1. PNAS 104 6. (doi:10.1073/pnas.0706678104)
34. Mortensen K, Christensen LL, Holst JJ & Orskov C 2003 GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regulatory Peptides 114 189-196. (doi:10.1016/S0167-0115(03)00125-3)
35. Nemoz-Gaillard E, Bosshard A, Regazzi R, Bernard C, Cuber JC, Takahashi M, Catsicas S, Chayvialle JA & Abello J 1998 Expression of SNARE proteins in enteroendocrine cell lines and functional role of tetanus toxin-sensitive proteins in cholecystokinin release. FEBS Letters 425 66-70. (doi:10.1016/S0014-5793(98)00209-9)
36. Orskov C, Holst JJ, Poulsen SS & Kirkegaard P 1987 Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30 874-881.
37. Ørskov C, Jeppesen J, Madsbad S & Holst J 1991 Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. Journal of Clinical Investigation 87 9. (doi:10.1172/JCI115012)
38. Orskov C, Jeppesen J, Madsbad S & Holst JJ 1991 Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. Journal of Clinical Investigation 87 415-423. (doi:10.1172/JCI115012)
39. Orskov C, Rabenhoj L, Wettergren A, Kofod H & Holst JJ 1994 Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43 535-539. (doi:10.2337/diab.43.4.535)
40. Parker HE, Habib AM, Rogers GJ, Gribble FM & Reimann F 2009 Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 52 289-298. (doi:10.1007/s00125-008-1202-x)
41. Pedersen J, Ugleholdt RK, Jørgensen SM, Windeløv JA, Grunddal KV, Schwartz TW, Füchtbauer EM, Poulsen SS, Holst PJ & Holst JJ 2013 Glucose metabolism is altered after loss of L cells and α-cells but not influenced by loss of K cells. American Journal of Physiology: Endocrinology and Metabolism 304 E60-E73. (doi:10.1152/ajpendo.00547.2011)
42. Ramshur EB, Rull TR & Wice BM 2002 Novel insulin/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo. Journal of Cellular Physiology 192 339-350. (doi:10.1002/jcp.10139)
43. Rehfeld JF 1998 Accurate measurement of cholecystokinin in plasma. Clinical Chemistry 44 991-1001.
44. Reimann F & Gribble FM 2002 Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes 51 2757-2763.
45. Reimann F, Williams L, da Silva Xavier G, Rutter GA & Gribble FM 2004 Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia 47 1592-1601. (doi:10.1007/s00125-004-1498-0)
46. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ & Gribble FM 2008 Glucose sensing in L cells: A primary cell study. Cell Metabolism 8 532-539. (doi:10.1016/j.cmet.2008.11.002)
47. Reimer RA, Darimont C, Gremlich S, Nicolas-Metral V, Ruegg UT & Mace K 2001 A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology 142 4522-4528. (doi:10.1210/endo.142.10.8415)
48. Rindi G, Grant GN, Yiangou Y, Ghatei MA, Bloom SR, Bautch VL, Solcia E & Polat JM 1990 Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. American Journal of Pathology 136 1349-1363.
49. Roth KA, Kim S & Gordon JI 1992 Immunocytochemical studies suggest two pathways for enteroendocrine cell differentiation in the colon. American Journal of Physiology 263 G174-180.
50. Sidhu SS, Thompson DG, Warhurst G, Case RM & Benson RS 2000 Fatty acid-induced cholecystokinin secretion and changes in intracellular Ca2+ in two enteroendocrine cell lines, STC-1 and GLUTag. The Journal of Physiology 528 165-176.
51. Stadil F & Rehfeld JF 1973 Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scandinavian Journal of Gastroenterology 8 101-112.
52. Svendsen B, Pedersen J, Albrechtsen NJ, Hartmann B, Torang S, Rehfeld JF, Poulsen SS & Holst JJ 2015 An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine. Endocrinology 156 847-857. (doi:10.1210/en.2014-1710)
53. Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K & Egan JM 2006 Human duodenal enteroendocrine cells: Source of both incretin peptides, GLP-1 and GIP. American Journal of Physiology: Endocrinology and Metabolism 290 E550-E559.
54. Torang S, Veedfald S, Rosenkilde MM, Hartmann B & Holst JJ 2015 The anorexic hormone Peptide YY3-36 is rapidly metabolized to inactive Peptide YY3-34 in vivo. Physiological Reports 3 e12455. (doi:10.14814/phy2.12455)
55. Wewer Albrechtsen NJ, Hartmann B, Veedfald S, Windelov JA, Plamboeck A, Bojsen-Moller KN, Idorn T, Feldt-Rasmussen B, Knop FK, Vilsboll T, et al. 2014 Hyperglucagonaemia analysed by glucagon sandwich ELISA: Nonspecific interference or truly elevated levels? Diabetologia 57 1919-1926. (doi:10.1007/s00125-014-3283-z)
56. Wewer Albrechtsen NJ, Bak MJ, Hartmann B, Christensen LW, Kuhre RE, Deacon CF & Holst JJ 2015a Stability of glucagon-like peptide 1 and glucagon in human plasma. Endocrine Connections 4 50-57. (doi:10.1530/EC-14-0126)
57. Wewer Albrechtsen NJ, Torang S, Hornburg D, Albrechtsen R, Janus C, Jepsen SL, Veedfald S, Meissner F, Mann M, Deacon CF, et al. 2015b A novel immune-based approach for measurement of the anorectic gut hormone oxyntomodulin: Changes after gastric bypass surgery. Diabetes 64 A532.